Document is current

Article History

Received: 8 June 2017

Accepted: 7 December 2017

First Online: 18 January 2018

Ethics approval and consent to participate

: The institutional review board of the Johns Hopkins Bloomberg School of Public Health reviewed and approved the initial protocol on 9 July 2015, IRB nmber 00006303. Individual clinical centers received approval from their respective IRBs as follows: University of Arkansas, 7 April 2015, protocol 203507; Central Arkansas Veterans Healthcare System institutional review board, 17 August 2015, protocol 639677-3; Western Institutional Review Board, 16 August 2015, protocol 20150480; University Hospitals Case Medical Center institutional review board, 26 May 2015, protocol 05-15-11; Emory University institutional review board, 28 May 2015, IRB00080186; Johns Hopkins Medicine institutional review board, 6 April 2015; IRB00064958; University of Rochester institutional review board, 23 August 2015, RSRB 56395; Roper St. Francis institutional review board, 06 May 2015, protocol 736159-1; Sunnybrook Health Sciences Centre research ethics board, 24 September 2015, 505-2014; Wake Forest University Health Sciences institutional review board, 1 May 2015, IRB 31928; Yale university institutional review board, 10 June 2015, protocol 1503015481. These institutional review boards approved all subsequent amendments to the ADMET 2 protocol. ADMET 2 is being conducted in accordance with the Declaration of Helsinki. Informed consent from both the study participant and his or her caregiver is required prior to study entry and administration of any intervention. Copies of the informed consent template are attached as an appendix.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.